Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Salek

Showing results (11-20 of 141) with videos related to

Pageof 15
Sort By:
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker
Frontiers in Pharmacology|October 27, 2018
Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory GuidelinesHasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek
Dermatology (Basel, Switzerland)|October 4, 2007
The practical reality of using a patient-reported outcome measure in a routine dermatology clinicSam Salek, Alaw Roberts, Andrew Y Finlay
Therapeutic Innovation & Regulatory Science|February 8, 2020
Patients' Perspectives of the Pharmaceutical Regulatory and Reimbursement Systems in Istanbul, TurkeyEmel Mashaki Ceyhan, Stuart Walker, Sam Salek
Frontiers in Pharmacology|December 25, 2014
Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documentsJames Leong Wai Yeen, Sam Salek, Stuart Walker
Therapeutic Innovation & Regulatory Science|December 1, 2020
Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration InitiativeTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Epilepsy & Behavior : E&B|February 24, 2007
Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31)Eva Tlusta, Ales Kubena, Sam Salek, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines - part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.
Therapeutic Innovation & Regulatory Science|January 2, 2021
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and OpportunitiesTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Pageof 15

Showing results (11-20 of 141) with videos related to

Sort By:
Pageof 15
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines--part 1: the development of a new model using multi-criteria decision analysis; part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker
Frontiers in Pharmacology|October 27, 2018
Quality, Non-clinical and Clinical Considerations for Biosimilar Monoclonal Antibody Development: EU, WHO, USA, Canada, and BRICS-TM Regulatory GuidelinesHasumati Rahalkar, Hacer Coskun Cetintas, Sam Salek
Dermatology (Basel, Switzerland)|October 4, 2007
The practical reality of using a patient-reported outcome measure in a routine dermatology clinicSam Salek, Alaw Roberts, Andrew Y Finlay
Therapeutic Innovation & Regulatory Science|February 8, 2020
Patients' Perspectives of the Pharmaceutical Regulatory and Reimbursement Systems in Istanbul, TurkeyEmel Mashaki Ceyhan, Stuart Walker, Sam Salek
Frontiers in Pharmacology|December 25, 2014
Strategy for communicating benefit-risk decisions: a comparison of regulatory agencies' publicly available documentsJames Leong Wai Yeen, Sam Salek, Stuart Walker
Therapeutic Innovation & Regulatory Science|December 1, 2020
Evaluating the Success of ZaZiBoNa, the Southern African Development Community Collaborative Medicines Registration InitiativeTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Epilepsy & Behavior : E&B|February 24, 2007
Psychometric properties of the Czech version of the Quality of Life in Epilepsy Inventory (QOLIE-31)Eva Tlusta, Ales Kubena, Sam Salek, et al.
Pharmacoepidemiology and Drug Safety|June 5, 2007
A quantitative approach to benefit-risk assessment of medicines - part 2: the practical application of a new modelFilip Mussen, Sam Salek, Stuart Walker, et al.
Therapeutic Innovation & Regulatory Science|September 19, 2018
Quality of Regulatory Decision-Making Practices: Issues Facing Companies and AgenciesMagdalena Bujar, Neil McAuslane, Sam Salek, et al.
Therapeutic Innovation & Regulatory Science|January 2, 2021
Evaluation of the Regulatory Review Process in Zimbabwe: Challenges and OpportunitiesTariro Sithole, Gugu Mahlangu, Sam Salek, et al.
Pageof 15